| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Crispr Therapeutics | 2,601,814 | 52,036,000 | 43.50% | ||
| 2 | PARATEK PHARMACEUTICALS INC | 1,301,413 | 19,977,000 | 16.70% | ||
| 3 | SIENTRA INC | 2,199,012 | 18,692,000 | 15.62% | ||
| 4 | NOVAN INC COM | 200,000 | 5,376,000 | 4.49% | ||
| 5 | CHIASMA INC | 2,080,595 | 3,953,000 | 3.30% | ||
| 6 | Proteon Therapeutics | 2,017,872 | 3,632,000 | 3.04% | ||
| 7 | CymaBay Therapeutics | 1,600,000 | 2,720,000 | 2.27% | ||
| 8 | DERMIRA INC | 70,000 | 2,122,000 | 1.77% | ||
| 9 | LOMBARD MEDICAL INC | 3,473,452 | 2,032,000 | 1.70% | ||
| 10 | CELLECTIS S A | 100,000 | 1,691,000 | 1.41% | ||
| 11 | HISTOGENICS CORP | 888,889 | 1,440,000 | 1.20% | ||
| 12 | SENSEONICS HOLDINGS INC | 516,882 | 1,375,000 | 1.15% | ||
| 13 | ANTHERA PHARMACEUTICALS I | 861,723 | 1,174,000 | 0.98% | ||
| 14 | IMMUNE DESIGN CORP COM | 197,300 | 1,075,000 | 0.90% | ||
| 15 | ADAPTIMMUNE THERAPEUTICS PLC | 250,000 | 1,003,000 | 0.84% | ||
| 16 | Dicerna Pharmaceuticals | 337,825 | 973,000 | 0.81% | ||
| 17 | Innocoll | 537,235 | 360,000 | 0.30% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-001929, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
